Aldosterone, Histone Demethylase and Cardiovascular Disease

醛固酮、组蛋白去甲基化酶与心血管疾病

• 批准号: 7923955
• 负责人: GORDON H WILLIAMS
• 金额: $ 62.16万
• 依托单位: BRIGHAM AND WOMEN'S HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-09-01 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7923955
• 关键词: Abdomen; Address; Adrenal Cortex; Adrenal Glands; Aldosterone; Alleles; Androgens; Angiotensin II; Angiotensinogen; Animal Model; Animals; Blood Pressure; Blood Vessels; California; Candidate Disease Gene; Cardiac; Cardiovascular Diseases; Cells; Characteristics; Clinical Research; Corticotropin; Data; Defect; Deltastab; Diet; Endothelial Cells; Enzyme Interaction; Enzymes; Estrogens; Functional disorder; Gene Expression; Genes; Genetic; Genetic Markers; Genetic Polymorphism; Genomics; Genotype; Goals; Gonadal Steroid Hormones; Heterozygote; Hispanics; Histones; Hormonal; Hormones; Human; Hypertension; In Vitro; Individual; Injury; Intake; Kidney; Knockout Mice; Link; Lysine; Mediating; Messenger RNA; Metabolism; Methylation; Mineralocorticoid Receptor; Minor; Modeling; Molecular; Nucleotides; Pathway interactions; Peptidyl-Dipeptidase A; Phenotype; Polymorphic Microsatellite Marker; Population; Potassium; Proteins; Protocols documentation; Receptor Activation; Receptor, Angiotensin, Type 1; Research Personnel; Research Project Grants; Role; Small Interfering RNA; Sodium; Sodium Chloride; Steroid Receptors; Steroids; Structure; Techniques; Testing; Tissues; Transcription Coactivator; Translational Research; Universities; Urine; Variant; base; cohort; db/db mouse; design; in vivo; knock-down; neutrophil; normotensive; programs; public health relevance; response; salt sensitive; text searching

DESCRIPTION (provided by applicant): For the past 20 years, we have studied the genetic underpinnings of hormonal factors leading to hypertension (HTN) in the HyperPATH cohort. From these studies, we have identified several associations between single nucleotide polymorphic (SNP) markers on candidate genes and specific intermediate phenotypes of the HTN. This proposal will focus on one of these identified phenotype/genotype associations. The intermediate phenotype is derived from the aldosterone (ALDO) response to angiotensin II (ANGII) on a sodium-restricted intake. This phenotype is heritable in the hypertensive population, is bimodally distributed in the hypertensive but not normotensive population and the hypertensive intermediate phenotype consists of those subjects in the lower mode that comprise 25% of hypertensives and <2% of normotensives. Associated with this subset is an enhanced sodium sensitivity of blood pressure and a defect in the vasculature, specifically the renovasculature. The genetic mechanisms responsible for these effects are unclear. One candidate is the recently described, first identified, histone demethylase that is linked to and whose action is modified by steroids---lysine-specific demethylase 1 (LSD1). A positive association between SNPs in LSD1 and ALDO response to ANGII was only observed in hypertensives and not normotensives. We then extended our studies in two ways: assessing LSD1 SNPs relationship to other phenotypic characteristics in humans (the minor allele also was associated with low urine ALDO levels on a high salt diet and sodium sensitivity of BP) and studying in experimental animals the relationship between LSD1, ALDO, the mineralocorticoid receptor (MR), and vascular injury. Our preliminary data suggest that LSD1: is present in vascular and cardiac tissue; is regulated by NA intake; is decreased by ALDO with the reversal by administering an MR antagonist; and is reduced in a CV injury model with parallel increases in its level and reduction in CV damage with MR blockade. The overall goal of the present proposal is to expand on these preliminary findings by characterizing the mechanisms underlying the interactions between LSD1, ALDO and the vasculature and their involvement in the pathophysiology of cardiovascular disease. Three approaches will be used. 1) We will assess phenotypic associations to polymorphism in the LSD1 gene to other genes and in the HyperPATH cohort and in a different cohort. 2) We will define LSD1's role in ALDO secretion. 3) We will extend our mechanistic studies of LSD1 from the adrenal to the vasculature. Thus, these positive results have formed the basis of the present proposal: a translational research project based on preliminary results from both the bench and the clinical research center. We will use in vivo and in vitro studies on vessels and adrenals in both humans (from our HyperPATH cohort) and animals (the LSD1 heterozygote knockout mouse where the LSD1 levels are 50% of that in the wild type). Vascular reactivity of vessels, molecular biologic and cell biologic techniques will be used. PUBLIC HEALTH RELEVANCE: Aldosterone is a hormone secreted by the adrenal gland whose function traditionally has been assumed to be to modify the kidney's ability to excrete potassium and sodium. However, recently aldosterone also has been implicated in having a major, adverse impact on the vasculature and by extension cardiovascular disease by uncertain mechanisms. This project is designed to assess one of those mechanisms thereby providing entrie to developing more directed therapy to treat cardiovascular diseases.

描述（由申请人提供）：在过去的20年中，我们研究了导致高性同步队列中高血压（HTN）的激素因子的遗传基础。从这些研究中，我们确定了候选基因上的单核苷酸多态性（SNP）标记与HTN的特定中间表型之间的几个关联。该建议将集中于这些确定的表型/基因型关联之一。中间表型源自对钠限制摄入量对血管紧张素II（Angii）的醛固酮（Aldo）的反应。这种表型在高血压人群中是可遗传的，在高血压但不是正常的人群中分布双峰，高血压中间表型由较低模式的受试者组成，占高血压的25％和<2％的正常剂。与该子集相关的是血压的钠敏感性和脉管系统中的缺陷，尤其是Renovasculation。负责这些作用的遗传机制尚不清楚。一个候选者是最近描述的，首先鉴定出的组蛋白脱甲基酶，其作用被类固醇（赖氨酸特异性脱甲基酶1（LSD1））所修饰。 LSD1中的SNP与Aldo对ANGII的反应之间的正相关仅在高血压和不正常的敏感性中观察到。然后，我们通过两种方式扩展了研究：评估人类的LSD1 SNP与其他表型特征（次要等位基因也与低盐饮食上的尿液Aldo水平低和BP的钠敏感性有关），并在实验动物中研究LSD1，ALDO，ALDO，ALDO，ALDO，ALDO，ALDO，ALDO，NERERALEROLOCOID受体受体（MR）和血管损伤。我们的初步数据表明LSD1：存在于血管和心脏组织中。受NA摄入量调节；通过管理MR拮抗剂，Aldo会随着Aldo的逆转而减少；并在简历损伤模型中减少，并平行地增加了其水平，并通过MR封锁降低了CV损伤。本提案的总体目的是通过表征LSD1，Aldo和脉管系统之间相互作用的机制来扩展这些初步发现，及其参与心血管疾病的病理生理学。将使用三种方法。 1）我们将评估LSD1基因与其他基因以及超同胞队列和不同队列中的多态性的表型关联。 2）我们将定义LSD1在Aldo分泌中的作用。 3）我们将将LSD1的机械研究从肾上腺扩展到脉管系统。因此，这些积极的结果构成了本提案的基础：基于基准和临床研究中心的初步结果的转化研究项目。我们将在人类（来自我们的超人类群）和动物（LSD1杂合子基因敲除小鼠中的血管和肾上腺的体内和体外研究，其中LSD1水平在野生型中的50％）。将使用血管，分子生物学和细胞生物学技术的血管反应性。公共卫生相关性：醛固酮是肾上腺分泌的激素，传统上被认为是修改肾脏排泄钾和钠的能力。然而，最近，醛固酮也与不确定的机制对脉管系统产生了重大的，不利的影响。该项目旨在评估这些机制之一，从而为开发更多有定向疗法以治疗心血管疾病提供了参与。